Stuttgart - Delayed Quote • EUR Apellis Pharmaceuticals Inc (1JK.SG) Follow Add holdings 16.57 +1.85 +(12.54%) As of 8:06:55 AM GMT+2. Market Open. Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure Undo Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 1JK.SG 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: 1JK.SG View More All News Press Releases SEC Filings Why Apellis Pharmaceuticals, Inc. (APLS) Skyrocketed On Monday Apellis Pharmaceuticals' Funding Gaps, Weak Syfovre Sales Cloud Outlook, BofA Says Apellis price target lowered to $20 from $28 at Scotiabank Apellis Pharmaceuticals downgraded by Raymond James due to ’added uncertainty’ Is Apellis Pharmaceuticals, Inc. (APLS) The Best Stock That Will Bounce Back? Apellis' Q1 Earnings and Revenues Miss Estimates, Stock Down Apellis Pharmaceuticals Inc (APLS) Q1 2025 Earnings Call Highlights: Strong Market Leadership ... Why Apellis Pharmaceuticals Wilted on Wednesday Apellis Pharmaceuticals (APLS) Reports Q1 Earnings: What Key Metrics Have to Say Apellis Pharmaceuticals, Inc. (APLS) Reports Q1 Loss, Lags Revenue Estimates Apellis Pharmaceuticals Reports First Quarter 2025 Financial Results Related Tickers IM8N.F Insmed Incorporated 63.00 +2.44% 7RG0.F Regulus Therapeutics Inc. 6.80 0.00% RNA Avidity Biosciences, Inc. 33.17 +7.07% ACAD ACADIA Pharmaceuticals Inc. 21.47 -0.49% PRTA Prothena Corporation plc 4.6600 +1.53%